Tech Company Financing Transactions
Great Lakes Pharmaceuticals Funding Round
Great Lakes Pharmaceuticals closed a $3.1 million Series B funding round on 7/27/2010. Backers included CLS, Early Stage Partners and North Coast Angel Fund.
Transaction Overview
Company Name
Announced On
7/27/2010
Transaction Type
Venture Equity
Amount
$3,100,000
Round
Series B
Investors
CLS (Lead Investor) (Gino DiSciullo)
Early Stage Partners (Michael Bunker)
Proceeds Purpose
The Company intends to use the funds to complete a pivotal clinical study of B-Lock, an antimicrobial catheter lock solution.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2000 Auburn Dr. 200
Beachwood, OH 44122
USA
Beachwood, OH 44122
USA
Phone
Website
Email Address
Overview
Great Lakes Pharmaceuticals develops products for the prevention of infections linked with indwelling catheters.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Gino DiSciullo
Chief Executive Officer
Krzysztof Appelt
Browse more venture capital transactions:
Prev: 7/27/2010: Workstreamer venture capital transaction
Next: 7/28/2010: Verient venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs